Design considerations for workflow management systems use in production genomics research and the clinic
Abstract The changing landscape of genomics research and clinical practice has created a need for computational pipelines capable of efficiently orchestrating complex analysis stages while handling large volumes of data across heterogeneous computational environments. Workflow Management Systems (Wf...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71063f0cca8645c6a434d845100e2c90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:71063f0cca8645c6a434d845100e2c90 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:71063f0cca8645c6a434d845100e2c902021-11-08T10:55:45ZDesign considerations for workflow management systems use in production genomics research and the clinic10.1038/s41598-021-99288-82045-2322https://doaj.org/article/71063f0cca8645c6a434d845100e2c902021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99288-8https://doaj.org/toc/2045-2322Abstract The changing landscape of genomics research and clinical practice has created a need for computational pipelines capable of efficiently orchestrating complex analysis stages while handling large volumes of data across heterogeneous computational environments. Workflow Management Systems (WfMSs) are the software components employed to fill this gap. This work provides an approach and systematic evaluation of key features of popular bioinformatics WfMSs in use today: Nextflow, CWL, and WDL and some of their executors, along with Swift/T, a workflow manager commonly used in high-scale physics applications. We employed two use cases: a variant-calling genomic pipeline and a scalability-testing framework, where both were run locally, on an HPC cluster, and in the cloud. This allowed for evaluation of those four WfMSs in terms of language expressiveness, modularity, scalability, robustness, reproducibility, interoperability, ease of development, along with adoption and usage in research labs and healthcare settings. This article is trying to answer, which WfMS should be chosen for a given bioinformatics application regardless of analysis type?. The choice of a given WfMS is a function of both its intrinsic language and engine features. Within bioinformatics, where analysts are a mix of dry and wet lab scientists, the choice is also governed by collaborations and adoption within large consortia and technical support provided by the WfMS team/community. As the community and its needs continue to evolve along with computational infrastructure, WfMSs will also evolve, especially those with permissive licenses that allow commercial use. In much the same way as the dataflow paradigm and containerization are now well understood to be very useful in bioinformatics applications, we will continue to see innovations of tools and utilities for other purposes, like big data technologies, interoperability, and provenance.Azza E. AhmedJoshua M. AllenTajesvi BhatPrakruthi BurraChristina E. FliegeSteven N. HartJacob R. HeldenbrandMatthew E. HudsonDave Deandre IstantoMichael T. KalmbachGregory D. KapraunKatherine I. KendigMatthew Charles KendziorEric W. KleeNate MattsonChristian A. RossSami M. SharifRamshankar VenkatakrishnanFaisal M. FadlelmolaLiudmila S. MainzerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-18 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Azza E. Ahmed Joshua M. Allen Tajesvi Bhat Prakruthi Burra Christina E. Fliege Steven N. Hart Jacob R. Heldenbrand Matthew E. Hudson Dave Deandre Istanto Michael T. Kalmbach Gregory D. Kapraun Katherine I. Kendig Matthew Charles Kendzior Eric W. Klee Nate Mattson Christian A. Ross Sami M. Sharif Ramshankar Venkatakrishnan Faisal M. Fadlelmola Liudmila S. Mainzer Design considerations for workflow management systems use in production genomics research and the clinic |
description |
Abstract The changing landscape of genomics research and clinical practice has created a need for computational pipelines capable of efficiently orchestrating complex analysis stages while handling large volumes of data across heterogeneous computational environments. Workflow Management Systems (WfMSs) are the software components employed to fill this gap. This work provides an approach and systematic evaluation of key features of popular bioinformatics WfMSs in use today: Nextflow, CWL, and WDL and some of their executors, along with Swift/T, a workflow manager commonly used in high-scale physics applications. We employed two use cases: a variant-calling genomic pipeline and a scalability-testing framework, where both were run locally, on an HPC cluster, and in the cloud. This allowed for evaluation of those four WfMSs in terms of language expressiveness, modularity, scalability, robustness, reproducibility, interoperability, ease of development, along with adoption and usage in research labs and healthcare settings. This article is trying to answer, which WfMS should be chosen for a given bioinformatics application regardless of analysis type?. The choice of a given WfMS is a function of both its intrinsic language and engine features. Within bioinformatics, where analysts are a mix of dry and wet lab scientists, the choice is also governed by collaborations and adoption within large consortia and technical support provided by the WfMS team/community. As the community and its needs continue to evolve along with computational infrastructure, WfMSs will also evolve, especially those with permissive licenses that allow commercial use. In much the same way as the dataflow paradigm and containerization are now well understood to be very useful in bioinformatics applications, we will continue to see innovations of tools and utilities for other purposes, like big data technologies, interoperability, and provenance. |
format |
article |
author |
Azza E. Ahmed Joshua M. Allen Tajesvi Bhat Prakruthi Burra Christina E. Fliege Steven N. Hart Jacob R. Heldenbrand Matthew E. Hudson Dave Deandre Istanto Michael T. Kalmbach Gregory D. Kapraun Katherine I. Kendig Matthew Charles Kendzior Eric W. Klee Nate Mattson Christian A. Ross Sami M. Sharif Ramshankar Venkatakrishnan Faisal M. Fadlelmola Liudmila S. Mainzer |
author_facet |
Azza E. Ahmed Joshua M. Allen Tajesvi Bhat Prakruthi Burra Christina E. Fliege Steven N. Hart Jacob R. Heldenbrand Matthew E. Hudson Dave Deandre Istanto Michael T. Kalmbach Gregory D. Kapraun Katherine I. Kendig Matthew Charles Kendzior Eric W. Klee Nate Mattson Christian A. Ross Sami M. Sharif Ramshankar Venkatakrishnan Faisal M. Fadlelmola Liudmila S. Mainzer |
author_sort |
Azza E. Ahmed |
title |
Design considerations for workflow management systems use in production genomics research and the clinic |
title_short |
Design considerations for workflow management systems use in production genomics research and the clinic |
title_full |
Design considerations for workflow management systems use in production genomics research and the clinic |
title_fullStr |
Design considerations for workflow management systems use in production genomics research and the clinic |
title_full_unstemmed |
Design considerations for workflow management systems use in production genomics research and the clinic |
title_sort |
design considerations for workflow management systems use in production genomics research and the clinic |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/71063f0cca8645c6a434d845100e2c90 |
work_keys_str_mv |
AT azzaeahmed designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT joshuamallen designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT tajesvibhat designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT prakruthiburra designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT christinaefliege designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT stevennhart designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT jacobrheldenbrand designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT matthewehudson designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT davedeandreistanto designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT michaeltkalmbach designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT gregorydkapraun designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT katherineikendig designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT matthewcharleskendzior designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT ericwklee designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT natemattson designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT christianaross designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT samimsharif designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT ramshankarvenkatakrishnan designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT faisalmfadlelmola designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic AT liudmilasmainzer designconsiderationsforworkflowmanagementsystemsuseinproductiongenomicsresearchandtheclinic |
_version_ |
1718442536365719552 |